AK Medical Holdings Limited

HKSE 1789.HK

AK Medical Holdings Limited Cash and Short-Term Investments for the year ending December 31, 2023: USD 102.35 M

AK Medical Holdings Limited Cash and Short-Term Investments is USD 102.35 M for the year ending December 31, 2023, a -32.24% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

AK Medical Holdings Limited Cash and Short-Term Investments for the year ending December 31, 2022 was USD 151.06 M, a 14.11% change year over year.
AK Medical Holdings Limited Cash and Short-Term Investments for the year ending December 31, 2021 was USD 132.38 M, a -4.15% change year over year.
AK Medical Holdings Limited Cash and Short-Term Investments for the year ending December 31, 2020 was USD 138.11 M, a 94.72% change year over year.
AK Medical Holdings Limited Cash and Short-Term Investments for the year ending December 31, 2019 was USD 70.93 M, a 6.80% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

HKSE: 1789.HK

AK Medical Holdings Limited

CEO	Mr. Zhijiang Li
IPO Date	Dec. 20, 2017
Location	China
Headquarters	Xingye Building
Employees	974
Sector	Health Care
Industries Pharmaceuticals

Description

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spine replacement implants; and 3D-printed products, such as 3D-printed hip replacement implants, 3D-printed artificial vertebral bodies, and 3D-printed spinal interbody cages. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.

Key trends

Past 5 years